No. | Product Name | CAS No. | Certificate / Documents |
---|---|---|---|
1 | Fosfomycin Trometamol | 78964-85-9 | WC/DMF |
2 | Fosfomycin Calcium | 26472-47-9 | DMF |
3 | Fosfomycin Sodium (Non-sterile) | 26016-99-9 | DMF |
4 | Tenofovir Alafenamide | 379270-37-8 | DMF |
5 | Troxerutin | 7085-55-4 | GMP/DMF |
6 | Sodium,8-[(2-hydroxybenzoyl)amino]octanoate(SNAC) | 203787-91-1 | DMF |
7 | Fosfomycin Phenethylamine | 25383-07-7 | DMF |
8 | 3-(4-fluorophenyl)--2-Methylpropanoyl chloride (SOLE 3) | 1017183-70-8 | TP |
9 | (5-Fluoro-2-methyl-1H-inden-3-yl)acetic acid (SOLE 6) | 32004-66-3 | TP |
10 | (R)-9-(2-Phosphonomethoxy propyl) Adenine (PMPA) | 147127-20-6 | DMF |
11 | Ethyl 8-bromooctanoate | 29823-21-0 | TP |
12 | Methyl 3-(cyanomethyl)benzoate | 68432-92-8 | TP |
13 | 3-(1-Cyanoethyl)-benzoic acid | 5537-71-3 | TP |
14 | Methyl 3,4,5-Trimethoxybenzoate | 1916-07-0 | TP |
15 | 2,3,4-Trimethoxybenzaldehyde | 2103-57-3 | TP |
16 | 2,3,4-Trihydroxybenzaldehyde | 2144-08-3 | TP |
The above-mentioned products are produced or sold only in countries or regions where the relevant patents have expired in areas without patent protection
No. | Product Name | CAS No. | Stage |
---|---|---|---|
1 | Baloxavir Marboxil | 1985606-14-1 | Pilot |
2 | Dibenzo[b,e]thiepin-11-ol, 7,8-difluoro-6,11-dihydro- | 1985607-83-7 | Pilo |
3 | Mirogabalin | 1138245-13-2 | Lab |
4 | Bicyclo[3.2.0]hept-3-en-6-one,3-ethyl-, (1R,5S) | 1235479-61-4 | Pilot |
5 | [(1R, 5S, 6S)-3-ethyl-6-(nitromethyl) bicyclic [3.2.0 hept-3-en-6-yl] benzylamine acetate salt | 1644251-52-4 | Pilot |
6 | Agomelatine | 138112-76-2 | Lab |
7 | 7-Methoxy-1-naphthylacetonitrile | 138113-08-3 | Pilot |
8 | Finerenone | 1050477-31-0 | Pilot |
9 | 4-Cyano-2-Methoxybenzaldehyde | 21962-45-8 | Pilot |
10 | 4-Amino-5-Methylpyridin-2-Ol | 95306-64-2 | Pilot |
11 | Upadacitinib | 1310726-60-3 | Pilot |
12 | UP1((3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester) | 1428243-26-8 | Pilot |
13 | Fluralaner | 864731-61-3 | Pilot |
14 | 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl] -2-methylbenzoic acid | 864725-62-2 | Pilot |
The above-mentioned products are produced or sold only in countries or regions where the relevant patents have expired in areas without patent protection
No. | Product Name | CAS No. | Certificate / Documents |
---|---|---|---|
1 | Amoxicillin | EP/USP/BP | GMP/CEP/DMF |
2 | PVPP | FCC | CEP/DMF |
3 | Ammonium Glycyrrhizinate | EP | GMP/DMF |
4 | Ivermectin | EP/CEP | GMP/DMF |
5 | Orlistat | USP | GMP/DMF |
6 | Thiamine hydrochloride(VB1) | USP/BP | GMP/DMF |
7 | Pyridoxine hydrochloride(VB6) | USP/BP | GMP/DMF |
8 | Polydeoxyribonucleotide (PDRN) | In-house | TP |
9 | D-ribose | USP | TP |
10 | Spirulina Powder | In-house | TP |
11 | Tilmicosin Phosphate | In-house | GMP |
12 | Lactulose | USP/EP | TP |
13 | Glucosamine Sulfate Potassium Chloride | USP | TP |
14 | Guanine | In-house | TP |
The above-mentioned products are produced or sold only in countries or regions where the relevant patents have expired in areas without patent protection
Copyright Nanjing Dorra Pharmaceutical Technology Co.,Ltd. @ 2018 China All Rights Reserved 蘇ICP備12056923號-1